-
J.B. Chemicals & Pharmaceuticals Ltd reports 43% YoY net sales growth for Q3 FY23
The company reported net sales of Rs. 1,423 crore for the quarter ended December 31, 2022, compared to Rs. 991 crore in the same quarter last year.
-
J.B. Chemicals & Pharmaceuticals Ltd to acquire 25% stake in Puridify Water Solutions Pvt. Ltd.
The acquisition will strengthen J.B. Chemicals' presence in the water purification market and enhance its product portfolio.
-
J.B. Chemicals & Pharmaceuticals Ltd launches new manufacturing facility in Dahej, Gujarat
The new facility will expand the company's production capacity and meet the growing demand for its products.
-
J.B. Chemicals & Pharmaceuticals Ltd Announces Q3FY23 Results
J.B. Chemicals & Pharmaceuticals Ltd has announced its financial results for the third quarter (Q3) of the fiscal year 2022-23 (FY23).
-
J.B. Chemicals & Pharmaceuticals Ltd Signs Joint Venture Agreement with Jubilant Pharmova
J.B. Chemicals & Pharmaceuticals Ltd has signed a joint venture agreement with Jubilant Pharmova to form a new company that will manufacture and market generic pharmaceuticals in India.
-
J.B. Chemicals & Pharmaceuticals Ltd Launches New Drug for Treatment of Type 2 Diabetes
J.B. Chemicals & Pharmaceuticals Ltd has launched a new drug for the treatment of type 2 diabetes.
-
J.B. Chemicals & Pharmaceuticals Subsidiary JB Chemicals & Pharmaceuticals and NutraHealth Collaborate on Innovative Health Projects
JB Chemicals & Pharmaceuticals Ltd, the flagship company of J.B. Chemicals & Pharmaceuticals Group, has announced a strategic collaboration with NutraHealth, a leading player in the nutraceutical industry, to develop and launch innovative health products. This partnership will leverage the strengths of both companies to bring forth groundbreaking solutions that cater to the evolving needs of consumers.
-
J.B. Chemicals & Pharmaceuticals Q3 FY23 Results: Net Profit Jumps 12% to Rs 103.6 Crore
J.B. Chemicals & Pharmaceuticals Ltd (JBCPL), a leading player in the Indian pharmaceutical industry, reported a 12.2% year-on-year (YoY) increase in its consolidated net profit to Rs 103.6 crore for the third quarter ended December 2022 (Q3 FY23). The company's revenue from operations also witnessed a healthy growth of 10.5% YoY to Rs 831.4 crore during the quarter.
-
J.B. Chemicals & Pharmaceuticals Q2 Consolidated Net Profit Rises 28.5% to Rs 78.7 Crore
J.B. Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceutical company, has reported a 28.5% year-on-year (YoY) growth in its consolidated net profit to Rs 78.7 crore for the second quarter of the fiscal year 2022-23 (Q2 FY23).
-
J.B. Chemicals & Pharmaceuticals Ltd Q3FY23 Results: Net Profit Rises 18% to Rs 279 Crore
The company's revenue from operations jumped 20.6% to Rs 1,421.4 crore in the quarter under review.
-
J.B. Chemicals & Pharmaceuticals Ltd Launches New API Facility in Gujarat
The facility will produce a range of APIs, including antibiotics, anti-infectives, and cardiovascular drugs.
-
J.B. Chemicals & Pharmaceuticals Ltd Partners with Biocon to Develop Novel Insulin Biosimilars
The partnership aims to develop and commercialize a portfolio of novel insulin biosimilars for the treatment of diabetes.